$EMED
Electromedical Technologies, Inc

2021 Q2 Form 10-Q Financial Statement

#000110465921105239 Filed on August 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2019 Q4
Revenue $203.0K $136.8K $829.7K
YoY Change 48.41% -23.98%
Cost Of Revenue $49.74K $18.00K $238.5K
YoY Change 176.42% -60.99%
Gross Profit $153.2K $118.8K $591.2K
YoY Change 29.01% -11.21%
Gross Profit Margin 75.49% 86.84% 71.25%
Selling, General & Admin $677.9K $936.7K $2.177M
YoY Change -27.63% 203.42%
% of Gross Profit 442.44% 788.71% 368.22%
Research & Development $4.000K $82.85K
YoY Change -81.02%
% of Gross Profit 3.37% 14.01%
Depreciation & Amortization $10.94K $5.469K $10.94K
YoY Change 100.0% -59.55%
% of Gross Profit 7.14% 4.61% 1.85%
Operating Expenses $677.9K $936.7K $2.260M
YoY Change -27.63% 184.04%
Operating Profit -$524.7K -$817.9K -$1.669M
YoY Change -35.85% 317.28%
Interest Expense $772.5K $14.56K -$54.81K
YoY Change 5204.77% -225.75%
% of Operating Profit
Other Income/Expense, Net -$249.9K -$22.35K -$20.90K
YoY Change 1018.2% 61.58%
Pretax Income -$774.5K -$840.3K -$1.744M
YoY Change -7.82% 279.49%
Income Tax
% Of Pretax Income
Net Earnings -$774.5K -$840.3K -$1.744M
YoY Change -7.82% 279.48%
Net Earnings / Revenue -381.63% -614.42% -210.23%
Basic Earnings Per Share -$0.11
Diluted Earnings Per Share -$0.11 -$40.90K -$56.72K
COMMON SHARES
Basic Shares Outstanding 35.82M
Diluted Shares Outstanding 35.82M

Balance Sheet

Concept 2021 Q2 2020 Q2 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $380.4K $127.1K $0.00
YoY Change 199.37%
Cash & Equivalents $380.4K $127.1K $0.00
Short-Term Investments
Other Short-Term Assets $9.450K $68.62K $65.83K
YoY Change -86.23% -33.55%
Inventory $286.2K $39.97K $24.69K
Prepaid Expenses
Receivables $15.90K $18.69K $15.67K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $692.0K $254.4K $106.2K
YoY Change 172.05% 15.15%
LONG-TERM ASSETS
Property, Plant & Equipment $738.3K $760.2K $771.1K
YoY Change -2.88% -2.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.60K $65.86K $25.58K
YoY Change -79.35%
Total Long-Term Assets $751.9K $826.0K $796.7K
YoY Change -8.98% -9.1%
TOTAL ASSETS
Total Short-Term Assets $692.0K $254.4K $106.2K
Total Long-Term Assets $751.9K $826.0K $796.7K
Total Assets $1.444M $1.080M $902.9K
YoY Change 33.64% -4.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $212.5K $361.2K $282.2K
YoY Change -41.17% 46.68%
Accrued Expenses $218.4K $266.8K $289.8K
YoY Change -18.16% 55.19%
Deferred Revenue $0.00
YoY Change
Short-Term Debt $0.00 $39.50K $0.00
YoY Change -100.0%
Long-Term Debt Due $904.7K $1.940M $1.685M
YoY Change -53.35% 11.99%
Total Short-Term Liabilities $2.213M $2.723M $2.297M
YoY Change -18.75% 17.75%
LONG-TERM LIABILITIES
Long-Term Debt $688.7K $715.7K $779.4K
YoY Change -3.77% -34.19%
Other Long-Term Liabilities $12.37K $21.96K $11.31K
YoY Change -43.65% -2.92%
Total Long-Term Liabilities $12.37K $737.6K $790.7K
YoY Change -98.32% -33.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.213M $2.723M $2.297M
Total Long-Term Liabilities $12.37K $737.6K $790.7K
Total Liabilities $2.914M $3.461M $3.087M
YoY Change -15.81% 1.11%
SHAREHOLDERS EQUITY
Retained Earnings -$20.85M
YoY Change
Common Stock $436.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.470M -$2.381M -$2.184M
YoY Change
Total Liabilities & Shareholders Equity $1.444M $1.080M $902.9K
YoY Change 33.64% -4.35%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2019 Q4
OPERATING ACTIVITIES
Net Income -$774.5K -$840.3K -$1.744M
YoY Change -7.82% 279.48%
Depreciation, Depletion And Amortization $10.94K $5.469K $10.94K
YoY Change 100.0% -59.55%
Cash From Operating Activities -$401.3K -$246.6K -$17.25K
YoY Change 62.71% -6.41%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 200.9K 334.8K 17.25K
YoY Change -39.99% 27.06%
NET CHANGE
Cash From Operating Activities -401.3K -246.6K -17.25K
Cash From Investing Activities
Cash From Financing Activities 200.9K 334.8K 17.25K
Net Change In Cash -200.3K 88.20K 0.000
YoY Change -327.13%
FREE CASH FLOW
Cash From Operating Activities -$401.3K -$246.6K -$17.25K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Registrant Name
EntityRegistrantName
Electromedical Technologies, Inc
dei Entity Central Index Key
EntityCentralIndexKey
0001715819
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2020Q1 elcq Term Of Consulting Agreement
TermOfConsultingAgreement
P12M
elcq Initial Warranty Period
InitialWarrantyPeriod
P3Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56192
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-2619815
dei Entity Address Address Line1
EntityAddressAddressLine1
16561 N. 92nd Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste. 101
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85260
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
880-7888
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
380443
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
264913
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15895
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17694
CY2021Q2 us-gaap Inventory Net
InventoryNet
286180
CY2020Q4 us-gaap Inventory Net
InventoryNet
78712
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9445
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
285860
CY2021Q2 us-gaap Assets Current
AssetsCurrent
691963
CY2020Q4 us-gaap Assets Current
AssetsCurrent
647179
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13601
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20601
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
738281
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
749219
CY2021Q2 us-gaap Assets
Assets
1443845
CY2020Q4 us-gaap Assets
Assets
1416999
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
212498
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
262614
CY2021Q2 elcq Credit Cards Payable
CreditCardsPayable
17341
CY2020Q4 elcq Credit Cards Payable
CreditCardsPayable
23710
CY2021Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
218351
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
201814
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
28651
CY2020Q4 elcq Discount On Convertible Promissory Notes Current
DiscountOnConvertiblePromissoryNotesCurrent
1217757
CY2021Q2 elcq Discount On Convertible Promissory Notes Current
DiscountOnConvertiblePromissoryNotesCurrent
1277255
CY2021Q2 elcq Convertible Promissory Notes Payable Current
ConvertiblePromissoryNotesPayableCurrent
624896
CY2020Q4 elcq Convertible Promissory Notes Payable Current
ConvertiblePromissoryNotesPayableCurrent
257398
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
12846
CY2021Q2 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
27332
CY2020Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
28260
CY2021Q2 elcq Related Party Notes Payable Current
RelatedPartyNotesPayableCurrent
252500
CY2020Q4 elcq Related Party Notes Payable Current
RelatedPartyNotesPayableCurrent
332500
CY2020Q4 elcq Payroll Protection Program Loan
PayrollProtectionProgramLoan
39500
CY2021Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
859767
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
831852
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2212685
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2019145
CY2021Q2 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
532765
CY2020Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
546552
CY2021Q2 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
155900
CY2020Q4 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
154302
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12374
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15603
CY2021Q2 us-gaap Liabilities
Liabilities
2913724
CY2020Q4 us-gaap Liabilities
Liabilities
2735602
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
500000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
500000
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
355000
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
355000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43790608
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27175800
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
436
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
269
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19026098
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7957860
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20851413
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9631732
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1469879
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1318603
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1443845
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1416999
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
202954
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
136755
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
369394
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
351625
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
49741
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
17995
us-gaap Cost Of Revenue
CostOfRevenue
91332
us-gaap Cost Of Revenue
CostOfRevenue
82508
CY2021Q2 us-gaap Gross Profit
GrossProfit
153213
CY2020Q2 us-gaap Gross Profit
GrossProfit
118760
us-gaap Gross Profit
GrossProfit
278062
us-gaap Gross Profit
GrossProfit
269117
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
677871
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
936669
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2367254
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1524819
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-524658
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-817909
us-gaap Operating Income Loss
OperatingIncomeLoss
-2089192
us-gaap Operating Income Loss
OperatingIncomeLoss
-1255702
CY2021Q2 us-gaap Interest Expense
InterestExpense
772480
CY2020Q2 us-gaap Interest Expense
InterestExpense
14562
us-gaap Interest Expense
InterestExpense
1832782
CY2020Q2 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-7784
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-7784
us-gaap Interest Expense
InterestExpense
29510
CY2021Q2 elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-522610
elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-537408
CY2021Q2 elcq Other Nonoperating Income Expenses
OtherNonoperatingIncomeExpenses
-4
elcq Other Nonoperating Income Expenses
OtherNonoperatingIncomeExpenses
-432
elcq Other Nonoperating Income Expenses
OtherNonoperatingIncomeExpenses
1500
elcq Debt Instrument Forgiveness Of Debt
DebtInstrumentForgivenessOfDebt
-50082
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-249874
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-22346
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1245724
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-35794
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-774532
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-840255
us-gaap Net Income Loss
NetIncomeLoss
-3334916
us-gaap Net Income Loss
NetIncomeLoss
-1291496
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35815408
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20543804
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32206268
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19355818
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1318603
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
693826
CY2021Q1 elcq Adjustments To Additional Paid In Capital Warrants Issued In Conjunction With Convertible Promissory Notes
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithConvertiblePromissoryNotes
420096
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
380103
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
604901
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2560384
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1780061
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
974314
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
110400
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-774532
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1469879
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-2184437
CY2020Q1 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
7352
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
290000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5265
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-451241
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-2333061
CY2020Q2 elcq Stock Issued During Period Value In Conjunction With Convertible Promissory Notes
StockIssuedDuringPeriodValueInConjunctionWithConvertiblePromissoryNotes
42969
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
8800
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
600000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
37149
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000
CY2020Q2 elcq Adjustments To Additional Paid In Capital Warrants Issued In Conjunction With Convertible Promissory Notes
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithConvertiblePromissoryNotes
48231
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5481
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-840255
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-2380686
us-gaap Net Income Loss
NetIncomeLoss
-3334916
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
207468
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15277
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-276415
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2785
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-7000
us-gaap Net Income Loss
NetIncomeLoss
-1291496
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6052
us-gaap Share Based Compensation
ShareBasedCompensation
1409127
us-gaap Share Based Compensation
ShareBasedCompensation
937895
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10938
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10938
elcq Forgiveness Of Debt Instrument
ForgivenessOfDebtInstrument
49783
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-7784
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1727201
elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-537408
elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1799
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9073
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
40282
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-43116
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
80615
elcq Increase Decrease In Credit Card Payables
IncreaseDecreaseInCreditCardPayables
-6369
elcq Increase Decrease In Credit Card Payables
IncreaseDecreaseInCreditCardPayables
-1572
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
49953
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-15626
elcq Increase Decrease In Customer Deposits Operating Activities
IncreaseDecreaseInCustomerDepositsOperatingActivities
-28651
elcq Increase Decrease In Customer Deposits Operating Activities
IncreaseDecreaseInCustomerDepositsOperatingActivities
76250
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-3229
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
10654
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-728507
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-245923
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-35665
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
39500
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
155900
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
13117
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
6236
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-80000
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
69500
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
950000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
100000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
12846
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
844037
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
372999
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
115530
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
127076
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
264913
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
380443
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127076
us-gaap Interest Paid Net
InterestPaidNet
23648
us-gaap Interest Paid Net
InterestPaidNet
19404
CY2021Q2 us-gaap Deferred Income
DeferredIncome
32106
CY2020Q4 us-gaap Deferred Income
DeferredIncome
35200
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
7352
elcq Warrants Common Stock And Beneficial Conversion Feature Issued In Conjunction With Convertible Promissory Note
WarrantsCommonStockAndBeneficialConversionFeatureIssuedInConjunctionWithConvertiblePromissoryNote
420096
elcq Warrants Common Stock And Beneficial Conversion Feature Issued In Conjunction With Convertible Promissory Note
WarrantsCommonStockAndBeneficialConversionFeatureIssuedInConjunctionWithConvertiblePromissoryNote
100000
elcq Derivative Liabilities Issued In Conjunction With Convertible Promissory Notes
DerivativeLiabilitiesIssuedInConjunctionWithConvertiblePromissoryNotes
1197607
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1354417
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
899987
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
899987
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration:underline;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities, certain disclosures at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant estimates affecting the financial statements have been prepared on the basis of the most current and best available information. However, actual results from the resolution of such estimates and assumptions may vary from those used in the preparation of the financial statements.</p>
elcq Accumulated Net Loss
AccumulatedNetLoss
12500000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-728507
elcq Working Capital Deficit
WorkingCapitalDeficit
1520722
elcq Sales Returns Allowance
SalesReturnsAllowance
6990
CY2020 elcq Sales Returns Allowance
SalesReturnsAllowance
6990
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
28651
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
161706
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
150768
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
738281
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
749219
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5469
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5469
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10938
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10938
CY2021Q2 us-gaap Receivables From Customers
ReceivablesFromCustomers
14900
CY2020Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
13800
CY2021Q2 us-gaap Due From Customer Acceptances
DueFromCustomerAcceptances
295
CY2020Q4 us-gaap Due From Customer Acceptances
DueFromCustomerAcceptances
0
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
28651
CY2021Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
859767
CY2020Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
831852
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
831852
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-537408
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
1197607
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-632284
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
859767
CY2021Q2 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
60000
CY2020Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
58000
elcq Standard Warranty Period
StandardWarrantyPeriod
P3Y
CY2021Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
14721
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
17483
elcq Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Outstanding Warrants Stock Options And Convertible Promissory Notes
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfOutstandingWarrantsStockOptionsAndConvertiblePromissoryNotes
95000000
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1842653
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1534653
CY2021Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1217757
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1277255
CY2021Q2 us-gaap Notes Payable
NotesPayable
624896
CY2020Q4 us-gaap Notes Payable
NotesPayable
257398
CY2020Q4 elcq Warrants Issued
WarrantsIssued
135000
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.50
CY2020Q4 elcq Fair Value Of Warrant
FairValueOfWarrant
190144
CY2021Q1 elcq Warrants Issued
WarrantsIssued
2500000
CY2021Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.40
CY2021Q1 elcq Fair Value Of Warrant
FairValueOfWarrant
420096
CY2021Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
716600
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1727201
CY2021Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1217757
CY2021Q2 elcq Additional Interest Expense
AdditionalInterestExpense
43260
CY2020Q2 elcq Additional Interest Expense
AdditionalInterestExpense
1257
elcq Additional Interest Expense
AdditionalInterestExpense
80572
elcq Additional Interest Expense
AdditionalInterestExpense
1257
CY2021Q2 elcq Interest Income Expense Related Party Net
InterestIncomeExpenseRelatedPartyNet
3785
CY2020Q2 elcq Interest Income Expense Related Party Net
InterestIncomeExpenseRelatedPartyNet
0
elcq Interest Income Expense Related Party Net
InterestIncomeExpenseRelatedPartyNet
6622
elcq Interest Income Expense Related Party Net
InterestIncomeExpenseRelatedPartyNet
0
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
831852
elcq Derivative Liabilities Conversion Of Notes Payable
DerivativeLiabilitiesConversionOfNotesPayable
-632284
elcq Derivative Liabilities Additions
DerivativeLiabilitiesAdditions
1197607
elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-537408
CY2021Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
859767
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
445000
CY2020Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10355
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14585
CY2020Q1 elcq Stock Issued During Period Value Per Share Issued For Services
StockIssuedDuringPeriodValuePerShareIssuedForServices
0.71
CY2020Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
200000
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
102000
CY2020Q1 us-gaap Share Price
SharePrice
0.51
CY2020Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
900000
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1818000
CY2020Q3 us-gaap Share Price
SharePrice
2.02
CY2021Q1 elcq Stock Issued During Period Value Conversion Of Convertible Note And Notes Payable
StockIssuedDuringPeriodValueConversionOfConvertibleNoteAndNotesPayable
190050
CY2021Q1 elcq Stock Issued During Period Shares Conversion Of Convertible Note And Notes Payable
StockIssuedDuringPeriodSharesConversionOfConvertibleNoteAndNotesPayable
1019113
CY2021Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1084120
CY2021Q1 elcq Stock Issued During Period Value Conversion Of Convertible Note And Notes Payable
StockIssuedDuringPeriodValueConversionOfConvertibleNoteAndNotesPayable
693837
CY2021Q1 elcq Stock Issued During Period Value Per Share Issued For Services
StockIssuedDuringPeriodValuePerShareIssuedForServices
0.64
CY2021Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
50000
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8400
CY2021Q2 elcq Stock Issued During Period Value Per Share Issued For Services
StockIssuedDuringPeriodValuePerShareIssuedForServices
0.168
CY2021Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1200000
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
102000
CY2021Q2 elcq Stock Issued During Period Value Per Share Issued For Services
StockIssuedDuringPeriodValuePerShareIssuedForServices
0.085
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
10000000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5481
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10946
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.71
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
445000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.71
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y3M18D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
420000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.71
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y3M18D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
445000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.71
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y3M18D
CY2021Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2500000
CY2021Q1 elcq Warrants Issued
WarrantsIssued
2500000
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.40
CY2021Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
420096
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
57695151

Files In Submission

Name View Source Status
0001104659-21-105239-index-headers.html Edgar Link pending
0001104659-21-105239-index.html Edgar Link pending
0001104659-21-105239.txt Edgar Link pending
0001104659-21-105239-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20210630.xsd Edgar Link pending
tmb-20210630x10q.htm Edgar Link pending
tmb-20210630x10q001.jpg Edgar Link pending
tmb-20210630x10q_htm.xml Edgar Link completed
tmb-20210630xex31d1.htm Edgar Link pending
tmb-20210630xex32d1.htm Edgar Link pending
tmb-20210630_cal.xml Edgar Link unprocessable
tmb-20210630_def.xml Edgar Link unprocessable
tmb-20210630_lab.xml Edgar Link unprocessable
tmb-20210630_pre.xml Edgar Link unprocessable